Clinical Trial Update: Nicotine Lozenge Bioequivalence Study [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of nicotine lozenges for smoking cessation has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• Nicotine lozenge (Nicorette) (nicotine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Smoking Cessation | Phase 1 | Status: COMPLETED | Results posted: 2013-04-26